Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Modus Operandi for Rehabilitating Aids with Tetrasilver Tetroxide Molecular Crystal Devices


Affiliations
1 Department of Bio-Engineering, School of Engineering, Vels Institute of Science, Technology and Advanced Studies, Pallavaram, Chennai– 600 117, Tamil Nadu, India
     

   Subscribe/Renew Journal


AIDS is a set of symptoms or syndrome, cause by HIV. AIDS stands for ‘Acquired Immune Deficiency Syndrome’ and HIV ‘Human Immune Deficiency Virus’. This disease damages the immune system has great extent and makes the body prone to infections and diseases. The susceptibility of the body to diseases increases if the syndrome progresses. AIDS is also referred to as advance HIV infection or late stage of HIV. People with HIV may develop AIDS if not diagnosed until late or don’t consistently take their antiretroviral therapy. The AIDS virus and AIDS symbiotic pathogens immunity suppressing moieties in humans is demolished by the use of the diamagnetic semiconducting molecular crystal tetra silver tetroxide Ag4O4. A single intravenous injection is required for the efficiency of the level 40 ppm of the human blood. The device accommodates 2 mono silver ions and 2 trivalent silver ions which is competent of firing and electrocuting the AIDS virus, pathogens and other ISM into the blood stream the electron triggered by a pathogen. When a proliferating virus and ISM fired continuously in a redox chelation mechanism then the resulting became a divalent silver moiety which binds to the active sites and destroy all of them. These devices are through innocuous and environmentally safe but yet, it may apply stress in liver which causes hepatomegaly, but keeps the liver function unaffected.

Keywords

AIDS, Silver Tetroxide, Molecualr Crystal Devices.
Subscription Login to verify subscription
User
Notifications
Font Size


  • www.medicalnewstoday.com
  • www.avert.org>about- hiv-aids
  • www.healthline.com
  • www.emedicinehealth.com
  • www.wikipedia.org
  • Medlineplus.gov>HIV aids
  • Antelman MS, inventor; Antelman Technologies Ltd, assignee. Method of curing AIDS with tetrasilver tetroxide molecular crystal devices. United States patent US 5, 676, 977. 1997 Oct 14.
  • Antelman MS, inventor; Jonas N and Co Inc, assignee. Divalent silver alkaline bactericide compositions. United States patent US 5, 073, 382. 1991 Dec 17.
  • Antelman MS, inventor; Antelman Technologies Ltd, assignee. Molecular crystal device for pharmaceuticals. United States patent US 5, 336, 499. 1994 Aug 9.
  • Antelman M, inventor; Marantech Holding LLC, assignee. Compositions using tetrasilver tetroxide and methods for management of skin conditions using same. United States patent application US 10/630, 737. 2004 Feb 5.
  • Antelman MS. Multivalent Silver Bactericides. InPRECIOUS METALS-CONFERENCE- 1992 (Vol. 16, pp. 151-151). PERGAMON PRESS.
  • Antelman MS, inventor; Antelman Technologies Ltd, assignee. Molecular crystal device for pharmaceuticals. United States patent US 5, 336, 499. 1994 Aug 9.
  • Antelman MS, inventor; Antelman Technologies Ltd, assignee. Molecular crystal redox device for pharmaceuticals. United States patent US 5, 571, 520. 1996 Nov 5.
  • Fox Jr CL, Modak SM, inventors; Columbia University of New York, assignee. Method of inhibiting the transmission of AIDS virus. United States patent US 4, 952, 411. 1990 Aug 28.
  • De Cuellar BR, Bello LA, inventors; Laboratorios Biochemie de Mexico, assignee. Method of manufacturing a composition for treating skin lesions. United States patent US 4, 828, 832. 1989 May 9.
  • Antelman MS, inventor; Antelman Technologies Ltd, assignee. Molecular crystal device for pharmaceuticals. United States patent US 5, 336, 499. 1994 Aug 9.
  • Antelman MS, inventor; Antelman Technologies Ltd, assignee. Method of curing AIDS with tetrasilver tetroxide molecular crystal devices. United States patent US 5, 676, 977. 1997 Oct 14.
  • Antelman MS. Anti-pathogenic multivalent silver molecular semiconductors. In PRECIOUS METALS-CONFERENCE- 1992 (Vol. 16, pp. 141-141). PERGAMON PRESS.
  • Antelman MS, inventor; Marantech Holding LLC, assignee. Compositions for facilitating skin growth and methods and articles using same. United States patent US 6, 669, 966. 2003 Dec 30.
  • Duesberg PH, Ellison BJ. Is The AIDS Virus A Science Fiction? Immunosuppressive Behavior, Not HIV, May Be the Cause of AIDS. Policy Review. 1990; 53:40-51.
  • Improvements in curing AIDS with tetra silver tetroxide molecular crystal devices. WO2003043537A1-2003-05-30 - 5334588 August 2, 1994 - Fox, jr.
  • Antelman MS, inventor; Antelman Technologies Ltd, assignee. Method of curing AIDS with tetrasilver tetroxide molecular crystal devices. United States patent US 5, 676, 977. 1997 Oct 14.
  • Method of curing AIDS with tetra silver tetroxide molecular crystal device.
  • US08658955 -1996-05-31 5089275 February 18, 1992 –Antelman
  • Antelman MS, inventor; Jonas N and Co Inc, assignee. Trivalent silver water treatment compositions. United States patent US 5, 223, 149. 1993 Jun 29.
  • Antelman MS, inventor; Jonas N and Co Inc, assignee. Divalent silver bactericide for water treatment. United States patent US 5, 017, 295. 1991 May 21.
  • Antelman MS. Divalent silver oxide bactericides. Patent Number. 1992 Feb.
  • Antelman MS, inventor; Jonas N and Co Inc, assignee. Divalent silver bactericide for water treatment. United States patent US 5, 017, 295. 1991 May 21.
  • US09552172 -2000-04-18 -tetra silver tetroxide treatment for skin conditions
  • JP2001549670A -2000-10-20-compositions and methods for the promotion and skin conditions the treatment of skin proliferation.
  • PCT/US2000/029115 – 2000-10-20- compositions and methods for facilitating skin growth and managing skin conditions.
  • Antelman MS, inventor; Marantech Holding LLC, assignee. Tetrasilver tetroxide treatment for skin conditions. United States patent US 6, 258, 385. 2001 Jul 10.
  • US10630737–2003-07-31- Compositions using tetra silver tetroxide and methods for management of skin conditions using same.
  • US11318648 –2005-12-27- Compositions using tetra silver tetroxide and methods for management of skin conditions using same.
  • Antelman MS, inventor; Marantech Holding LLC, assignee. Tetrasilver tetroxide treatment for skin conditions. United States patent US 6, 258, 385. 2001 Jul 10.
  • US4828832A-1989-05-09 –Methods of manufacturing a composition for treating skin lesions.
  • US6669966B1-2003-12-30-Composition for facilitating skin growth and methods and article
  • US20040022868A1-2004-02-05-Composition using tetra silver tetroxide and methods for management of skin condition.
  • www.medicalnewstoday.com
  • www.avert.org>about- HIV-aids
  • www.healthline.com
  • www.emedicinehealth.com
  • www.wikipedia.org
  • Medlineplus.gov>HIV aids

Abstract Views: 210

PDF Views: 0




  • Modus Operandi for Rehabilitating Aids with Tetrasilver Tetroxide Molecular Crystal Devices

Abstract Views: 210  |  PDF Views: 0

Authors

R. Thiruchelvi
Department of Bio-Engineering, School of Engineering, Vels Institute of Science, Technology and Advanced Studies, Pallavaram, Chennai– 600 117, Tamil Nadu, India
Aryaman Das
Department of Bio-Engineering, School of Engineering, Vels Institute of Science, Technology and Advanced Studies, Pallavaram, Chennai– 600 117, Tamil Nadu, India

Abstract


AIDS is a set of symptoms or syndrome, cause by HIV. AIDS stands for ‘Acquired Immune Deficiency Syndrome’ and HIV ‘Human Immune Deficiency Virus’. This disease damages the immune system has great extent and makes the body prone to infections and diseases. The susceptibility of the body to diseases increases if the syndrome progresses. AIDS is also referred to as advance HIV infection or late stage of HIV. People with HIV may develop AIDS if not diagnosed until late or don’t consistently take their antiretroviral therapy. The AIDS virus and AIDS symbiotic pathogens immunity suppressing moieties in humans is demolished by the use of the diamagnetic semiconducting molecular crystal tetra silver tetroxide Ag4O4. A single intravenous injection is required for the efficiency of the level 40 ppm of the human blood. The device accommodates 2 mono silver ions and 2 trivalent silver ions which is competent of firing and electrocuting the AIDS virus, pathogens and other ISM into the blood stream the electron triggered by a pathogen. When a proliferating virus and ISM fired continuously in a redox chelation mechanism then the resulting became a divalent silver moiety which binds to the active sites and destroy all of them. These devices are through innocuous and environmentally safe but yet, it may apply stress in liver which causes hepatomegaly, but keeps the liver function unaffected.

Keywords


AIDS, Silver Tetroxide, Molecualr Crystal Devices.

References